CERIDIAN HCM HOLDING INC (CDAY)

US15677J1088 - Common Stock

69.52  +0.07 (+0.1%)

After market: 69.52 0 (0%)

Fundamental Rating

3

CDAY gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 81 industry peers in the Professional Services industry. CDAY has a bad profitability rating. Also its financial health evaluation is rather negative. CDAY shows excellent growth, but is valued quite expensive already.



2

1. Profitability

1.1 Basic Checks

In the past year CDAY was profitable.
In the past year CDAY had a positive cash flow from operations.
In the past 5 years CDAY reported 4 times negative net income.
CDAY had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

CDAY has a worse Return On Assets (0.04%) than 61.25% of its industry peers.
The Return On Equity of CDAY (0.18%) is worse than 61.25% of its industry peers.
CDAY's Return On Invested Capital of 2.51% is on the low side compared to the rest of the industry. CDAY is outperformed by 63.75% of its industry peers.
Industry RankSector Rank
ROA 0.04%
ROE 0.18%
ROIC 2.51%
ROA(3y)-0.66%
ROA(5y)-0.4%
ROE(3y)-2.35%
ROE(5y)-1.42%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 0.28%, CDAY is doing worse than 61.25% of the companies in the same industry.
The Operating Margin of CDAY (7.74%) is comparable to the rest of the industry.
Looking at the Gross Margin, with a value of 42.19%, CDAY is in line with its industry, outperforming 55.00% of the companies in the same industry.
CDAY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.74%
PM (TTM) 0.28%
GM 42.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.28%
GM growth 5Y-0.66%

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CDAY is destroying value.
CDAY has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CDAY has been increased compared to 5 years ago.
The debt/assets ratio for CDAY has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 1.19, we must say that CDAY is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.19, CDAY is doing worse than 72.50% of the companies in the same industry.
The Debt to FCF ratio of CDAY is 22.77, which is on the high side as it means it would take CDAY, 22.77 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CDAY (22.77) is worse than 73.75% of its industry peers.
A Debt/Equity ratio of 0.53 indicates that CDAY is somewhat dependend on debt financing.
CDAY has a Debt to Equity ratio (0.53) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 22.77
Altman-Z 1.19
ROIC/WACC0.3
WACC8.28%

2.3 Liquidity

CDAY has a Current Ratio of 1.09. This is a normal value and indicates that CDAY is financially healthy and should not expect problems in meeting its short term obligations.
CDAY has a worse Current ratio (1.09) than 68.75% of its industry peers.
A Quick Ratio of 1.09 indicates that CDAY should not have too much problems paying its short term obligations.
CDAY's Quick ratio of 1.09 is on the low side compared to the rest of the industry. CDAY is outperformed by 66.25% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09

8

3. Growth

3.1 Past

CDAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 105.00%, which is quite impressive.
Measured over the past years, CDAY shows a quite strong growth in Earnings Per Share. The EPS has been growing by 19.61% on average per year.
The Revenue has grown by 21.63% in the past year. This is a very strong growth!
Measured over the past years, CDAY shows a quite strong growth in Revenue. The Revenue has been growing by 13.19% on average per year.
EPS 1Y (TTM)105%
EPS 3Y19.61%
EPS 5YN/A
EPS growth Q2Q85%
Revenue 1Y (TTM)21.63%
Revenue growth 3Y14.78%
Revenue growth 5Y13.19%
Revenue growth Q2Q19.61%

3.2 Future

CDAY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.72% yearly.
Based on estimates for the next years, CDAY will show a quite strong growth in Revenue. The Revenue will grow by 17.67% on average per year.
EPS Next Y76.11%
EPS Next 2Y49.35%
EPS Next 3Y40.92%
EPS Next 5Y42.72%
Revenue Next Year23.9%
Revenue Next 2Y19.31%
Revenue Next 3Y17.87%
Revenue Next 5Y17.67%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 56.52 indicates a quite expensive valuation of CDAY.
Based on the Price/Earnings ratio, CDAY is valued a bit more expensive than 75.00% of the companies in the same industry.
CDAY is valuated expensively when we compare the Price/Earnings ratio to 24.55, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 40.47, which means the current valuation is very expensive for CDAY.
68.75% of the companies in the same industry are cheaper than CDAY, based on the Price/Forward Earnings ratio.
CDAY is valuated expensively when we compare the Price/Forward Earnings ratio to 20.92, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 56.52
Fwd PE 40.47

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CDAY indicates a slightly more expensive valuation: CDAY is more expensive than 73.75% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CDAY is valued a bit more expensive than 72.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 202.88
EV/EBITDA 52.32

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CDAY's earnings are expected to grow with 40.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.74
PEG (5Y)N/A
EPS Next 2Y49.35%
EPS Next 3Y40.92%

0

5. Dividend

5.1 Amount

No dividends for CDAY!.
Industry RankSector Rank
Dividend Yield N/A

CERIDIAN HCM HOLDING INC

NYSE:CDAY (1/31/2024, 7:04:00 PM)

After market: 69.52 0 (0%)

69.52

+0.07 (+0.1%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap10.85B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 56.52
Fwd PE 40.47
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.74
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.04%
ROE 0.18%
ROCE
ROIC
ROICexc
ROICexgc
OM 7.74%
PM (TTM) 0.28%
GM 42.19%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)105%
EPS 3Y19.61%
EPS 5Y
EPS growth Q2Q
EPS Next Y76.11%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)21.63%
Revenue growth 3Y14.78%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y